PTC Therapeutics upgraded at Jefferies on Sephience
Source: SeekingAlpha
2026-05-27 13:06:17 ET
More on PTC Therapeutics
- PTC Therapeutics, Inc. (PTCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- PTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating Leverage
- PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call Transcript
- PTC Therapeutics climbs after guidance hike
- PTC outlines 2026 product revenue guidance of $750M-$850M driven by Sephience launch momentum
Read the full article on Seeking Alpha
For further details see:
PTC Therapeutics upgraded at Jefferies on Sephience
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
